North America Needles Market Research Report – Segmented By Product (Conventional Needles, Bevel Needles, Blunt Fill Needles, Filter Needles, Vented Needles, Safety Needles, Active Needles, Passive Needles), Delivery Mode, Material, End User & Country (The United States, Canada and Rest of North America) - Industry Analysis From 2025 to 2033
The North America needles market was valued at USD 2.86 billion in 2025 and is projected to reach USD 5.25 billion by 2033, growing at a CAGR of 7.9% during the forecast period from 2025 to 2033. The growth of the North America needles market is driven by the rising demand for vaccines, the increasing geriatric population, and the growing prevalence of chronic diseases such as diabetes. Expanding hospital infrastructure, increasing adoption of injectable therapies, and rising awareness regarding blood donation are further supporting market growth. Moreover, technological advancements in needle safety, precision, and ease of use, along with the growing trend of self-administration of drugs, are broadening the application scope of needles across healthcare settings in North America.
The North America needles market is witnessing steady growth across the region due to a well-established healthcare infrastructure, increasing healthcare expenditure, and the presence of major medical device manufacturers.
The North America needles market is characterized by the presence of established global manufacturers with strong distribution networks and extensive product portfolios. Leading companies are focusing on product innovation, safety-enhanced needle designs, and strategic partnerships to strengthen their market presence. Increased investments in research and development and the introduction of advanced safety needles are key competitive strategies. Prominent players operating in the North America needles market include Becton, Dickinson and Company, B. Braun Melsungen AG, Terumo Corporation, Smiths Medical, and Thermo Fisher Scientific.
The needles market in North America was valued at USD 2.86 billion in 2025. It is estimated to be growing at a CAGR of 7.9% and will be worth USD 5.25 billion by 2033.
The growing demand for vaccines, the increasing geriatric population, and a growing number of hospitals in North America majorly drive the needles market growth in North America. In addition, the demand for needles in the North American region is expected to be fuelled by the rising prevalence of chronic diseases such as diabetes. Around 425 million people had diabetes worldwide in 2018; by 2045, this number is expected to reach 640 million (Source: International Diabetes Federation). According to the data published by the IDF Diabetes Atlas, an estimated 51 million had diabetes in North America and the Caribbean, and this number is expected to grow to 57 million by 2030 and 63 million by 2045. As per the same source, one in every seven people had diabetes in North America and the Caribbean, and 931,000 died of diabetes in 2021. Therefore, with the increasing prevalence of diabetes globally, the demand for needles will increase during the forecast period.
In addition, several biotechnology and pharmaceutical companies are dedicated to developing new injectable drugs useful in treating chronic diseases, increasing the production of needles, and thus driving the market growth rate. The North American needles market is expected to experience significant growth, owing to increased people's awareness about donating blood, extensive R&D, which has introduced new needle technology with high safety and precision, and the growing demand for point-of-care diagnostics. In addition, the increase in the self-administration of drugs and the increasing use of safety needles will provide opportunities for market growth during the forecast period.
However, the increase in needlestick injuries and infections, the use of needle-free technology, and the growing attention to developing alternative drug delivery methods are the main factors expected to slow the market's growth. In addition, the factors limiting the growth of the market are the lack of qualified physicians and the anxiety related to needles. The North American needles market is further expected to face some challenges due to the reuse of needles, complications and mental factors associated with needles, the availability of other convenient dosage forms such as those administered orally, and poor health care reimbursement policies in developing and underdeveloped regions.
| REPORT METRIC | DETAILS |
| Market Size Available | 2024 to 2033 |
| Base Year | 2024 |
| Forecast Period | 2025 to 2033 |
| CAGR | 7.9% |
| Segments Covered | By Product, Delivery Mode, Material, End User and Region. |
| Various Analyses Covered | Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
| Regions Covered | U.S, Canada, Rest of North America |
| Market Leaders Profiled | Becton, Dickinson and Company, B. Braun Melsungen AG, Terumo Corporation, and Smiths Medical, Terumo Corporation, Smiths Medical, and Thermo Fisher Scientific. |
Based on type, the conventional needles segment had a major share of the North American needles market in 2024.
Based on product, the suture needles segment held the leading share of the North American market in 2024.
The stainless-steel needles segment is one of the most lucrative in the North American market and is forecasted to witness a healthy CAGR in the coming years.
The hospitals and clinics segment is anticipated to hold a leading share of the North American market in 2024.
The North American region accounted for the most significant global market share in 2024. The North American region is estimated to continue holding the largest global market share during the forecast period owing to factors such as the presence of a well-established healthcare infrastructure, increasing R&D activities by the market participants to bring new and effective products to the market, and the presence of several pharmaceutical, medical devices, and biotechnological companies. The U.S. led the needles market in the North American market, followed by Canada.
The U.S is expected to have a dominant share over Canada in the North American market during the forecast period. The growth of the U.S. needles market is primarily driven by the rising prevalence of diabetes and the presence of favorable reimbursement scenarios for needles; federal injection technology awareness initiatives, increased market penetration of major companies, and improved needle technologies are driving forward market growth in the U.S. Growing demand for healthcare, driven by the rapid aging of the population, increasing prevalence of diabetes and other chronic diseases, is driving the growth of the U.S. needles market. As a result, the value of the North American needles market is expected to grow slightly during the forecast period.
During the forecast period, the Canadian market is anticipated to hold a considerable share of the North American market and witness a healthy CAGR.
Some of the companies that are dominating the North American Needles market include
This research report on the North America Needles Market has been segmented and sub-segmented into the following categories.
By Type
By Product
By Delivery Mode
By Material
By End User
By Country
Frequently Asked Questions
The North America needles market includes the manufacturing, distribution, and use of medical needles across the U.S. and Canada for healthcare, diagnostics, and pharmaceutical applications.
Medical needles are hollow, sharp instruments used for injections, blood collection, drug delivery, biopsies, and other clinical procedures.
Key drivers include rising prevalence of chronic diseases, increasing vaccination programs, growth in diagnostic testing, and expanding healthcare infrastructure.
Common types include hypodermic needles, blood collection needles, pen needles, suture needles, biopsy needles, and safety needles.
Major applications include drug delivery, blood sampling, vaccination, insulin administration, and diagnostic procedures.
Hospitals, clinics, diagnostic laboratories, ambulatory surgical centers, and home healthcare settings are the main end users.
The United States leads the market due to high healthcare spending, advanced medical facilities, and strong demand for injectable therapies.
Challenges include needlestick injury risks, regulatory compliance requirements, pricing pressure, and medical waste management issues.
Key trends include increased adoption of safety-engineered needles, growth in disposable needle usage, and technological improvements in needle design.
The market is expected to grow steadily due to rising healthcare demand, expanding vaccination coverage, and increased focus on patient and worker safety.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from
$ 2000
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: sales@marketdataforecast.com
Reports By Region